We are pleased to announce the acquisition of Progenetics
In May 2025, hylabs acquired Progenetics.
Progenetics is an Israeli pioneering company for precision oncology.
Progenetics specializing in advanced genetic testing for cancer patients.
Progenetics offers the widest range of oncology tests available in Israel.
Progenetics collaborates with leading laboratories worldwide, works with all hospitals in Israel, and maintains strong ties with the oncology community.
Progenetics conducts thousands of tests annually, adhering to international standards for logistics and customer service.
Progenetics is also actively involved in academic research.